tiprankstipranks
Innate Pharma SA (IPHYF)
OTHER OTC:IPHYF
US Market
IPHYF
Innate Pharma SA
RESEARCH TOOLSreports
Want to see IPHYF full AI Analyst Report?

Innate Pharma SA (IPHYF) Financial Statements

27 Followers

Innate Pharma SA Financial Overview

Innate Pharma SA's market cap is currently $138.86M. The company's EPS TTM is $-0.55; its P/E ratio is -1.31; Innate Pharma SA is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 2.79M€ 12.62M€ 51.90M€ 49.64M€ 12.11M
Gross Profit€ 2.79M€ -31.86M€ 5.62M€ 6.01M€ -34.89M
Operating Income€ -57.36M€ -51.58M€ -12.67M€ -24.63M€ -47.83M
EBITDA€ -55.97M€ -50.99M€ -1.84M€ -61.30M€ -43.23M
Net Income€ -49.18M€ -49.47M€ -7.57M€ -58.10M€ -52.81M
Balance Sheet
Cash & Short-Term Investments€ 34.31M€ 80.77M€ 92.46M€ 101.48M€ 119.84M
Total Assets€ 62.72M€ 111.06M€ 184.19M€ 207.86M€ 267.50M
Total Debt€ 22.57M€ 31.37M€ 39.89M€ 42.25M€ 44.25M
Net Debt€ -5.52M€ -35.03M€ -30.71M€ -41.97M€ -59.51M
Total Liabilities€ 84.42M€ 102.22M€ 132.29M€ 153.71M€ 160.06M
Stockholders' Equity€ -21.70M€ 8.83M€ 51.90M€ 54.15M€ 107.44M
Cash Flow
Free Cash Flow€ -52.90M€ -7.29M€ -34.91M€ -20.28M€ -59.79M
Operating Cash Flow€ -52.76M€ -6.90M€ -32.56M€ -19.15M€ -58.46M
Investing Cash Flow€ 7.29M€ 9.20M€ 20.63M€ 1.88M€ -917.00K
Financing Cash Flow€ 6.07M€ -6.01M€ -1.97M€ -1.83M€ 26.82M
Currency in EUR

Innate Pharma SA Earnings and Revenue History

Income Statement >

Innate Pharma SA Debt to Assets

Balance Sheet >

Innate Pharma SA Cash Flow

Cash Flow >

Innate Pharma SA Forecast EPS vs Actual EPS

Earnings >